The price of Lantern Pharma Inc (NASDAQ: LTRN) closed at $9.92 in the last session, down -6.85% from day before closing price of $10.65. In other words, the price has decreased by -$0.73 from its previous closing price. On the day, 694257 shares were traded.
Ratios:
We take a closer look at LTRN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.18 and its Current Ratio is at 16.18. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 07, 2021, initiated with a Buy rating and assigned the stock a target price of $32.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 29 ’24 when Kreis Leslie W. sold 19,703 shares for $4.87 per share. The transaction valued at 95,954 led to the insider holds 60,256 shares of the business.
Fletcher Aaron G.L. sold 19,703 shares of LTRN for $95,954 on Feb 29 ’24. The 10% Owner now owns 60,256 shares after completing the transaction at $4.87 per share. On Feb 28 ’24, another insider, Fletcher Aaron G.L., who serves as the 10% Owner of the company, sold 74,297 shares for $4.85 each. As a result, the insider received 360,340 and left with 62,088 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LTRN now has a Market Capitalization of 114.40M and an Enterprise Value of 73.33M.
Stock Price History:
Over the past 52 weeks, LTRN has reached a high of $10.73, while it has fallen to a 52-week low of $2.38. The 50-Day Moving Average of the stock is 5.16, while the 200-Day Moving Average is calculated to be 4.45.
Shares Statistics:
According to the various share statistics, LTRN traded on average about 240.72K shares per day over the past 3-months and 643.65k shares per day over the past 10 days. A total of 10.72M shares are outstanding, with a floating share count of 7.89M. Insiders hold about 26.51% of the company’s shares, while institutions hold 10.93% stake in the company. Shares short for LTRN as of Feb 29, 2024 were 67.96k with a Short Ratio of 0.28, compared to 69.47k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.63% and a Short% of Float of 0.74%.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.43 for the current quarter, with a high estimate of -$0.43 and a low estimate of -$0.43, while EPS last year was -$0.36. The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.48 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$1.92 and -$2.06 for the fiscal current year, implying an average EPS of -$1.99. EPS for the following year is -$1.91, with 2 analysts recommending between -$1.81 and -$2.02.
